OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Beware, vaping e-cigarettes around children is adversely impacting their lung health	186
Vaping and CBD: can new technology overcome old problems?	121
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	112
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	101
Correction:British Thoracic Society Winter Meeting 2023	89
E-cigarette use in young adults and adolescents: not so safe?	87
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	80
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	78
Ultrafine particles and health: the next frontier in understanding air pollution hazards	76
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline	66
Lung development genes, adult lung function and cardiovascular comorbidities	64
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	63
Complex coexistence of COPD and cardiovascular disease	62
Ablation for lung cancer: hot or cold intervention	61
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	59
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	58
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	57
British Thoracic Society Guideline for pleural disease	53
Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study	53
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	53
Toxic metals and lung health: silent poisons?	50
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	50
Muscle memory: genetic factors underlying functional impairment in COPD	49
Delayed presentation of pulmonary Echinococcus in a patient with no major risk factors	48
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	48

Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B	47
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis	47
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	47
Ageing and ivacaftor: unravelling the long-term effects	47
Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark	47
Smartphones: a useful option for the pulmonary rehab toolkit?	46
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	45
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review	45
Lower airway microbiota in COPD and healthy controls	42
Tool in lesion verification of shape-sensing robotic-assisted bronchoscopy with cone beam CT in sampling peripheral pulmonary nodules	38
Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease	38
Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial	38